1. Home
  2. PCLA vs EVOK Comparison

PCLA vs EVOK Comparison

Compare PCLA & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$0.21

Market Cap

18.6M

ML Signal

HOLD

Logo Evoke Pharma Inc.

EVOK

Evoke Pharma Inc.

HOLD

Current Price

$10.96

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCLA
EVOK
Founded
2008
2007
Country
Japan
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
18.4M
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
PCLA
EVOK
Price
$0.21
$10.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
748.5K
30.4K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,065,197.00
$14,424,652.00
Revenue This Year
N/A
$58.96
Revenue Next Year
N/A
$57.99
P/E Ratio
N/A
N/A
Revenue Growth
5.26
67.40
52 Week Low
$0.25
$1.94
52 Week High
$9.80
$10.99

Technical Indicators

Market Signals
Indicator
PCLA
EVOK
Relative Strength Index (RSI) 19.99 84.79
Support Level $0.27 $10.66
Resistance Level $0.33 $10.99
Average True Range (ATR) 0.02 0.05
MACD -0.00 -0.19
Stochastic Oscillator 7.00 89.69

Price Performance

Historical Comparison
PCLA
EVOK

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: